title: High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.
authors.forename: V
authors.initials: V
authors.lastname: Grossmann
authors.forename: S
authors.initials: S
authors.lastname: Schnittger
authors.forename: F
authors.initials: F
authors.lastname: Poetzinger
authors.forename: A
authors.initials: A
authors.lastname: Kohlmann
authors.forename: A
authors.initials: A
authors.lastname: Stiel
authors.forename: C
authors.initials: C
authors.lastname: Eder
authors.forename: A
authors.initials: A
authors.lastname: Fasan
authors.forename: W
authors.initials: W
authors.lastname: Kern
authors.forename: T
authors.initials: T
authors.lastname: Haferlach
authors.forename: C
authors.initials: C
authors.lastname: Haferlach
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002869:Chromosome Aberrations; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009154:Mutation; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D011379:Prognosis; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics* / Q000378:metabolism*; D015398:Signal Transduction; D055815:Young Adult
chemical_list: D051788:Myeloid-Lymphoid Leukemia Protein; D016283:Proto-Oncogene Proteins p21(ras)